Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 05, 2022

Metformin to Prevent Anthropometric and Metabolic Complications of ADT in Men With Prostate Cancer Receiving Radical Radiotherapy

International Journal of Radiation Oncology, Biology, Physics

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Radiation Oncology, Biology, Physics
Metformin for Prevention of Anthropometric & Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 27;[EPub Ahead of Print], N Usmani, S Ghosh, KP Sanghera, AD Ong, R Koul, A Dubey, S Ahmed, H Quon, D Yee, M Parliament, G Sivananthan, W Hunter, B Danielson, L Rowe, M McDonald, JO Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading